USE OF A FORMULATION OF SILVER NANOPARTICLES AS AN INHIBITING AGENT OF THE PATHOGENICITY OF FUSARIUM LACERTARUM
The present invention aims to provide the use of an aqueous formulation of silver nanoparticles covered with protein hydrolyzate with contents of 12 mg/mL of metallic silver, 188 mg/mL of protein hydrolyzate, and 800 mg/mL of distilled water in the inhibition of the pathogenicity of the colonizing f...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention aims to provide the use of an aqueous formulation of silver nanoparticles covered with protein hydrolyzate with contents of 12 mg/mL of metallic silver, 188 mg/mL of protein hydrolyzate, and 800 mg/mL of distilled water in the inhibition of the pathogenicity of the colonizing fungus Fusarium Lacertarum. Herein, the tests to validate the invention demonstrate a decrease in the phytopathogenic potential between 55% and 66%.
La presente invención provee el uso de una formulación acuosa de nanopartículas de plata cubiertas con hidrolizado de proteína con contenidos de: 12 mg/mL de plata metálica, 188 mg/mL de hidrolizado de proteína y 800 mg/mL de agua destilada, en la inhibición de la patogenicidad del hongo colonizador Fusarium lacertarum. Donde los ensayos realizados para validación de la invención demuestran una disminución del potencial fitopatógeno entre un 55% y 66%. |
---|